Morphine/alcohol interaction: US FDA requests label updates

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2005年 / 1062卷 / 1期

关键词：

Public Health; Alcohol; Morphine; Alcohol Consumption; Medium Release;

D O I：

10.2165/00128415-200510620-00007

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：3 / 3

相关论文

共 50 条

[1] US FDA requests HRT label update to reflect WHIMS findings
[J]. Reactions Weekly, 2004, 989 (1) : 2 - 2
[2] US FDA requests butyrolactone recall
[J]. Reactions Weekly, 1999, 736 (1) : 2 - 2
[3] US FDA updates bisphosphonate labels
[J]. Reactions Weekly, 2010, 1324 (1) : 2 - 2
[4] FDA Updates Gleevec Label for GIST Patients
Schmidt, Charlie
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012, 104 (05) : 346 - 346
[5] FDA recommends label updates for some immunosuppressants
[J]. Reactions Weekly, 2009, 1261 (1) : 3 - 3
[6] FDA requests class label change for atypical antipsychotics
[J]. Reactions Weekly, 2003, 970 (1) : 2 - 2
[7] FDA rejects industry requests for food label revisions
不详
[J]. JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 1999, 99 (10) : 1206 - 1206
[8] US FDA approves Acetadote labelling updates
[J]. Reactions Weekly, 2006, 1093 (1) : 3 - 3
[9] US FDA requests voluntary withdrawal of bacitracin for injection
[J]. Reactions Weekly, 2020, 1791 (1) : 5 - 5
[10] FDA requests withdrawal of lorcaserin from US market
[J]. Reactions Weekly, 2020, 1792 (1) : 1 - 1

← 1 2 3 4 5 →